Literature DB >> 1788551

Colchicine intoxication: clinical pharmacology, risk factors, features, and management.

C Putterman1, E Ben-Chetrit, Y Caraco, M Levy.   

Abstract

The use of colchicine for acute gouty arthritis dates to ancient times. In recent years, colchicine also has been used successfully for various other rheumatic and nonrheumatic conditions. Colchicine is a safe drug when used according to established therapeutic guidelines. However, toxicity can be considerable if ingested intentionally or if the recommended doses are exceeded. Colchicine intoxication is characterized by multi-organ involvement and by the poor prognosis associated with administration of large amounts of the drug. Therapy is basically supportive and symptomatic because of the rapid distribution and binding of colchicine to the affected tissues. Use of anticolchicine antibodies is a novel approach that has shown promise in experimental models. Important research questions pertain to the effect of liver and kidney disease on colchicine metabolism, use of colchicine levels in the diagnosis of intoxication and for prognostication, and application of immunotoxicotherapy for colchicine poisoning in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788551     DOI: 10.1016/0049-0172(91)90003-i

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  17 in total

Review 1.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

2.  Fatal colchicine intoxication by ingestion of Gloriosa superba tubers.

Authors:  Karthik Gunasekaran; Divya Elizabeth Mathew; Thomas Isaiah Sudarsan; Ramya Iyyadurai
Journal:  BMJ Case Rep       Date:  2019-05-16

Review 3.  Fab antibody fragments: some applications in clinical toxicology.

Authors:  Robert J Flanagan; Alison L Jones
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Dynamic observation of bone marrow suppression and chromosomal aberrations in patients with acute colchicine poisoning.

Authors:  Yan-Qing Liu; Xiao-Xia Lu; Kai-Xun Hu; Xiao-Bo Peng; Yun Jiang; Li-Mei Han; Zhi-Qiang Ma; Ming-Fei Peng; Kun Wan; Xi-Gang Zhang; Ze-Wu Qiu
Journal:  World J Emerg Med       Date:  2022

5.  Pathogenic characteristics and treatment in 43 cases of acute colchicine poisoning.

Authors:  Xiaoxia Lu; Yanqing Liu; Chunyan Wang; Jianguang Dong; Lili Bai; Chengcheng Zhang; Renzheng Zhang; Chengwen Sun; Zewu Qiu
Journal:  Toxicol Res (Camb)       Date:  2021-07-29       Impact factor: 2.680

6.  Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.

Authors:  Dhaval K Shah; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-25       Impact factor: 2.745

Review 7.  Risks and benefits of drugs used in the management and prevention of gout.

Authors:  P G Conaghan; R O Day
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

8.  Case report: fatal poisoning with Colchicum autumnale.

Authors:  Miran Brvar; Tom Ploj; Gordana Kozelj; Martin Mozina; Marko Noc; Matjaz Bunc
Journal:  Crit Care       Date:  2004-01-02       Impact factor: 9.097

9.  Acute poisoning with autumn crocus (Colchicum autumnale L.).

Authors:  Miran Brvar; Gordana Kozelj; Martin Mozina; Matjaz Bunc
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 2.275

10.  Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.

Authors:  Jeroen Ch van der Hilst; Michel Moutschen; Peter E Messiaen; Bernard R Lauwerys; Steven Vanderschueren
Journal:  Biologics       Date:  2016-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.